These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 18325606

  • 1. Penciclovir is a potent inhibitor of feline herpesvirus-1 with susceptibility determined at the level of virus-encoded thymidine kinase.
    Hussein IT, Menashy RV, Field HJ.
    Antiviral Res; 2008 Jun; 78(3):268-74. PubMed ID: 18325606
    [Abstract] [Full Text] [Related]

  • 2. Substrate specificity and molecular modelling of the feline herpesvirus-1 thymidine kinase.
    Hussein IT, Miguel RN, Tiley LS, Field HJ.
    Arch Virol; 2008 Jun; 153(3):495-505. PubMed ID: 18196203
    [Abstract] [Full Text] [Related]

  • 3. Development of a quantitative real-time TaqMan PCR assay for testing the susceptibility of feline herpesvirus-1 to antiviral compounds.
    Hussein IT, Field HJ.
    J Virol Methods; 2008 Sep; 152(1-2):85-90. PubMed ID: 18597862
    [Abstract] [Full Text] [Related]

  • 4. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
    Sarisky RT, Quail MR, Clark PE, Nguyen TT, Halsey WS, Wittrock RJ, O'Leary Bartus J, Van Horn MM, Sathe GM, Van Horn S, Kelly MD, Bacon TH, Leary JJ.
    J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674
    [Abstract] [Full Text] [Related]

  • 5. Characterization of a thymidine kinase-deficient mutant of equine herpesvirus 4 and in vitro susceptibility of the virus to antiviral agents.
    Azab W, Tsujimura K, Kato K, Arii J, Morimoto T, Kawaguchi Y, Tohya Y, Matsumura T, Akashi H.
    Antiviral Res; 2010 Feb; 85(2):389-95. PubMed ID: 19931566
    [Abstract] [Full Text] [Related]

  • 6. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
    Shiota T, Lixin W, Takayama-Ito M, Iizuka I, Ogata M, Tsuji M, Nishimura H, Taniguchi S, Morikawa S, Kurane I, Mizuguchi M, Saijo M.
    Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
    [Abstract] [Full Text] [Related]

  • 7. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.
    Bae PK, Kim JH, Kim HS, Chung IK, Paik SG, Lee CK.
    Antiviral Res; 2006 Jul; 70(3):93-104. PubMed ID: 16546268
    [Abstract] [Full Text] [Related]

  • 8. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
    Saijo M, Suzutani T, Mizuta K, Kurane I, Morikawa S.
    Arch Virol; 2008 Jul; 153(2):303-14. PubMed ID: 18066636
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
    Okuda T, Kurokawa M, Matsuo K, Honda M, Niimura M, Shiraki K.
    J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reactivation of acyclovir-resistant thymidine kinase-deficient herpes simplex virus harbouring single base insertion within a 7 Gs homopolymer repeat of the thymidine kinase gene.
    Morfin F, Thouvenot D, Aymard M, Souillet G.
    J Med Virol; 2000 Oct; 62(2):247-50. PubMed ID: 11002255
    [Abstract] [Full Text] [Related]

  • 15. Comparison of HSV-1 thymidine kinase-dependent and -independent inhibition of replication-competent adenoviral vectors by a panel of drugs.
    Wildner O, Hoffmann D, Jogler C, Uberla K.
    Cancer Gene Ther; 2003 Oct; 10(10):791-802. PubMed ID: 14502232
    [Abstract] [Full Text] [Related]

  • 16. Acyclovir-resistant herpes simplex virus type 1 in intra-ocular fluid samples of herpetic uveitis patients.
    van Velzen M, Missotten T, van Loenen FB, Meesters RJ, Luider TM, Baarsma GS, Osterhaus AD, Verjans GM.
    J Clin Virol; 2013 Jul; 57(3):215-21. PubMed ID: 23582986
    [Abstract] [Full Text] [Related]

  • 17. Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity.
    Burrel S, Bonnafous P, Hubacek P, Agut H, Boutolleau D.
    Antiviral Res; 2012 Dec; 96(3):386-90. PubMed ID: 23041200
    [Abstract] [Full Text] [Related]

  • 18. Genotypic and phenotypic characterization of acyclovir-resistant herpes simplex viruses isolated from haematopoietic stem cell transplant recipients.
    Stránská R, van Loon AM, Polman M, Beersma MF, Bredius RG, Lankester AC, Meijer E, Schuurman R.
    Antivir Ther; 2004 Aug; 9(4):565-75. PubMed ID: 15456088
    [Abstract] [Full Text] [Related]

  • 19. Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus.
    Sauerbrei A, Deinhardt S, Zell R, Wutzler P.
    Antiviral Res; 2010 Jun; 86(3):246-52. PubMed ID: 20211650
    [Abstract] [Full Text] [Related]

  • 20. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M, Yasuda Y, Yabe H, Kato S, Suzutani T, De Clercq E, Niikura M, Maeda A, Kurane I, Morikawa S.
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.